Skip to main content

The Joint Corp(JYNT-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low7.84
Day High8.26
Open:8.16
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

Top Stories: The Joint Corp

Select a category then submit the form to load news
Tipranks
Joint Corp Earnings Call: Refranchising Trumps Soft Comps
Tipranks
Craig-Hallum Sticks to Its Hold Rating for Joint (JYNT)
Tipranks
Joint (JYNT) Gets a Hold from B. Riley Securities
Tipranks
Wall Street Analysts Are Bullish on Top Healthcare Picks
Tipranks
Joint Corp Reports Q4 Growth Amid Transformation Strategy
Motley Fool
The Joint (JYNT) Q4 2025 Earnings Call Transcript
GlobeNewswire
The Joint Corp. Reports 2025 Fourth Quarter and Full Year Financial Results
GlobeNewswire
The Joint Corp. to Report 2025 Fourth Quarter and Full Year Results on Thursday, March 12 and Host Conference Call and Webcast
Tipranks
Joint Reaches Governance Agreement With Bandera Partners
GlobeNewswire
The Joint Corp. Appoints Ron Stilwell SVP Operations and Patient Experience
Tipranks
Analysts Offer Insights on Healthcare Companies: Celcuity (CELC) and Joint (JYNT)
Tipranks
Joint Corp. Terminates Southern California Clinics Sale
GlobeNewswire
The Joint Corp. Signs Asset Purchase Agreement to Sell 22 Corporate Clinics in the Southeast and Delivers Notice to Terminate APA for 45 Clinics in California
Tipranks
Joint Corp’s Earnings Call: Growth Amid Challenges
Tipranks
The Joint Corp. Reports Q3 2025 Financial Growth
Tipranks
Joint Corp. Sells Clinics in $4.5M Deal
Tipranks
Analysts Offer Insights on Healthcare Companies: Joint (JYNT), Qiagen (QGEN) and Xtant Medical Holdings (XTNT)
GlobeNewswire
The Joint Corp. Reports Third Quarter 2025 Financial Results
GlobeNewswire
The Joint Corp. Board of Directors Authorizes an Additional $12 Million for Stock Repurchase Program
Tipranks
Craig-Hallum Keeps Their Hold Rating on Joint (JYNT)
GlobeNewswire
The Joint Corp. to Host Conference Call on Thursday, November 6th to Discuss Third Quarter 2025 Results
Tipranks
Joint Amends Credit Agreement with JPMorgan Chase
Tipranks
Joint Announces CFO Resignation and Separation Agreement
Tipranks
Joint Corp’s Earnings Call: Mixed Outlook Amid Growth and Challenges
Tipranks
The Joint Corp. Delays Form 10-Q Filing
Tipranks
Craig-Hallum Sticks to Their Hold Rating for Joint (JYNT)
Tipranks
Roth MKM Sticks to Its Buy Rating for Joint (JYNT)
Tipranks
The Joint Corp. Reports Q2 2025 Earnings Growth
Tipranks
Joint Corp. Reports Q2 2025 Financial Results
GlobeNewswire
The Joint Corp. Expects to Restate Full Year 2024 and First Quarter 2025 Financial Statements due to Overestimated Noncash Impairment Charges
Tipranks
Joint Corp. Sells Clinics, Acquires Developer Rights
Tipranks
Craig-Hallum Sticks to Their Hold Rating for Joint (JYNT)

Profile

The Joint Corp. is a healthcare franchisor of chiropractic clinics. The Company's plans include: Single Visit, Premium Wellness Plan and Wellness Plan. It also provides a family wellness plan. The Company also provides removal of subluxations. It operates its clinics across: Albany, New York; Austin, Texas; Brentwood, California; Fort Mill, South Carolina; Lubbock, Texas; Lynnwood, Washington; Middletown, New Jersey; San Antonio, Texas; San Diego, California and Spartanburg, South Carolina, among others. The Joint Corp. is headquartered in Scottsdale, Arizona.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.